Literature DB >> 35181232

Extreme prematurity: Risk and resiliency.

Genevieve L Taylor1, T Michael O'Shea2.   

Abstract

Individuals born extremely preterm (before 28 weeks of gestation) comprise only about 0.7% of births in the United States and an even lower proportion in other high resource countries. However, these individuals account for a disproportionate number of children with cerebral palsy, intellectual deficit, autism spectrum disorder, attention deficit hyperactivity disorder, and epilepsy. This review describes two large multiple center cohorts comprised of individuals born extremely preterm: the EPICURE cohort, recruited 1995 in the United Kingdom and the Republic of Ireland, and the Extremely Low Gestational Age Newborn (ELGAN), recruited 2002-2004 in five states in the United States. The primary focus of these studies has been neurodevelopmental disorders, but also of interest are growth, respiratory illness, and parent- and self-reported global health and well-being. Both of these studies indicate that among individuals born extremely preterm the risks of most neurodevelopmental disorders are increased. Early life factors that contribute to this risk include perinatal brain damage, some of which can be identified using neonatal head ultrasound, bronchopulmonary dysplasia, and neonatal systemic inflammation. Prenatal factors, particularly the family's socioeconomic position, also appear to contribute to risk. For most adverse outcomes, the risk is higher in males. Young adults born extremely preterm who have neurodevelopmental impairment, as compared to those without such impairment, rate their quality of life lower. However, young adults born extremely preterm who do not have neurodevelopmental impairments rate their quality of life as being similar to that of young adults born at term. Finally, we summarize the current state of interventions designed to improve the life course of extremely premature infants, with particular focus on efforts to prevent premature birth and on postnatal efforts to prevent adverse neurodevelopmental outcomes.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35181232      PMCID: PMC9247808          DOI: 10.1016/j.cppeds.2022.101132

Source DB:  PubMed          Journal:  Curr Probl Pediatr Adolesc Health Care        ISSN: 1538-3199


  204 in total

Review 1.  NICU Diet, Physical Growth and Nutrient Accretion, and Preterm Infant Brain Development.

Authors:  Mandy Brown Belfort; Sara E Ramel
Journal:  Neoreviews       Date:  2019-07

2.  Epigenome-wide DNA methylation in placentas from preterm infants: association with maternal socioeconomic status.

Authors:  Hudson P Santos; Arjun Bhattacharya; Elizabeth M Martin; Kezia Addo; Matt Psioda; Lisa Smeester; Robert M Joseph; Stephen R Hooper; Jean A Frazier; Karl C Kuban; T Michael O'Shea; Rebecca C Fry
Journal:  Epigenetics       Date:  2019-05-21       Impact factor: 4.528

3.  Neuropsychological Outcomes at 19 Years of Age Following Extremely Preterm Birth.

Authors:  Helen O'Reilly; Samantha Johnson; Yanyan Ni; Dieter Wolke; Neil Marlow
Journal:  Pediatrics       Date:  2020-01-10       Impact factor: 7.124

4.  Circulating biomarkers in extremely preterm infants associated with ultrasound indicators of brain damage.

Authors:  Alan Leviton; Elizabeth N Allred; Raina N Fichorova; T Michael O'Shea; Lynn A Fordham; Karl K C Kuban; Olaf Dammann
Journal:  Eur J Paediatr Neurol       Date:  2018-01-31       Impact factor: 3.140

5.  Autism spectrum disorder is associated with ventricular enlargement in a low birth weight population.

Authors:  Tammy Z Movsas; Jennifer A Pinto-Martin; Agnes H Whitaker; Judith F Feldman; John M Lorenz; Steven J Korzeniewski; Susan E Levy; Nigel Paneth
Journal:  J Pediatr       Date:  2013-02-11       Impact factor: 4.406

6.  Systemic responses of preterm newborns with presumed or documented bacteraemia.

Authors:  Alan Leviton; T Michael O'Shea; Francis J Bednarek; Elizabeth N Allred; Raina N Fichorova; Olaf Dammann
Journal:  Acta Paediatr       Date:  2011-12-07       Impact factor: 2.299

7.  The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability.

Authors:  K Costeloe; E Hennessy; A T Gibson; N Marlow; A R Wilkinson
Journal:  Pediatrics       Date:  2000-10       Impact factor: 7.124

8.  Neonatal cranial ultrasound lesions and developmental delays at 2 years of age among extremely low gestational age children.

Authors:  T Michael O'Shea; Karl C K Kuban; Elizabeth N Allred; Nigel Paneth; Marcello Pagano; Olaf Dammann; Lisa Bostic; Kara Brooklier; Samantha Butler; Donald J Goldstein; Gail Hounshell; Cecelia Keller; Susan McQuiston; Alice Miller; Steve Pasternak; Susan Plesha-Troyke; Joan Price; Elaine Romano; Katherine M Solomon; Amanda Jacobson; Sjirk Westra; Alan Leviton
Journal:  Pediatrics       Date:  2008-09       Impact factor: 7.124

9.  Using a count of neonatal morbidities to predict poor outcome in extremely low birth weight infants: added role of neonatal infection.

Authors:  Dirk Bassler; Barbara J Stoll; Barbara Schmidt; Elizabeth V Asztalos; Robin S Roberts; Charlene M T Robertson; Reg S Sauve
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

10.  Neurologic and developmental disability at six years of age after extremely preterm birth.

Authors:  Neil Marlow; Dieter Wolke; Melanie A Bracewell; Muthanna Samara
Journal:  N Engl J Med       Date:  2005-01-06       Impact factor: 91.245

View more
  2 in total

1.  Caregivers' perception of the role of the socio-environment on their extremely preterm child's well-being.

Authors:  Crisma J Emmanuel; Kathy A Knafl; Sharron L Docherty; Eric A Hodges; Janice K Wereszczak; Julie V Rollins; Rebecca C Fry; T Michael O'Shea; Hudson P Santos
Journal:  J Pediatr Nurs       Date:  2022-05-25       Impact factor: 2.523

2.  A mixed-effects two-part model for twin-data and an application on identifying important factors associated with extremely preterm children's health disorders.

Authors:  Baiming Zou; Hudson P Santos; James G Xenakis; Mike M O'Shea; Rebecca C Fry; Fei Zou
Journal:  PLoS One       Date:  2022-06-13       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.